Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RAMON CREIXELL

Allopathic & Osteopathic Physicians Family Medicine

NPI
1649263021
CMS profile
165591
Location
HOUSTON, TX

General Payments · PY2018–2024

$5,215.72

  • Reported across 287 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$431.63

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $431.63 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,243.09 79
PY2019 $685.80 46
PY2020 $606.35 40
PY2021 $1,060.72 49
PY2022 $828.70 37
PY2023 $359.43 20
PY2024 $431.63 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $14.97 07/17/2024 Food and Beverage Undisputed 01/23/2026 1104246337 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.44 06/19/2024 Food and Beverage Undisputed 01/23/2026 1086202468 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.04 09/17/2024 Food and Beverage Undisputed 01/23/2026 1086129306 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.85 07/10/2024 Food and Beverage Undisputed 01/23/2026 1118093662 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.52 08/21/2024 Food and Beverage Undisputed 01/23/2026 1118093664 CMS
Boston Scientific Corporation $54.68 02/12/2024 Food and Beverage Undisputed 01/23/2026 1092623366 CMS
Boston Scientific Corporation $86.95 02/20/2024 Food and Beverage Undisputed 01/23/2026 1092623368 CMS
Currax Pharmaceuticals LLC $13.62 12/16/2024 Food and Beverage Undisputed 01/23/2026 1089514690 CMS
Dexcom, Inc. $29.72 02/09/2024 Food and Beverage Undisputed 01/23/2026 1153329453 CMS
Dexcom, Inc. $26.31 04/12/2024 Food and Beverage Undisputed 01/23/2026 1153329455 CMS
Dexcom, Inc. $25.68 06/21/2024 Food and Beverage Undisputed 01/23/2026 1153329457 CMS
Dexcom, Inc. $27.55 10/25/2024 Food and Beverage Undisputed 01/23/2026 1153329459 CMS
Novo Nordisk Inc $24.67 09/30/2024 Food and Beverage Undisputed 01/23/2026 1096618116 CMS
Seqirus USA Inc $19.86 02/21/2024 Food and Beverage Undisputed 01/23/2026 1125633611 CMS
Sumitomo Pharma America, Inc. $21.79 05/21/2024 Food and Beverage Undisputed 01/23/2026 1148841408 CMS
Sumitomo Pharma America, Inc. $15.98 08/28/2024 Food and Beverage Undisputed 01/23/2026 1148841410 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.